World / Science & Health Nov 5, 2022
Study shows new booster improves protection for older people, Pfizer says
U.S. officials are hoping that the encouraging results will improve what has so far been a dismal public response to the retooled shots.
U.S. officials are hoping that the encouraging results will improve what has so far been a dismal public response to the retooled shots.
The administration has gotten much right, but its response has been hampered by confusing messaging, a lack of focus on testing, fear of political blowback and the virus’ unpredictability.
The first boosters are likely to go to nursing home residents and health care workers, followed by other older people.
The concerns about the shot mirror those about AstraZeneca’s, which European regulators began investigating last month after some recipients developed blood clots.
U.S. President Joe Biden announced Tuesday that there would be enough doses of the coronavirus vaccine available for the entire adult population in the United States by the end of May, although he said it would take longer to actually inoculate everyone, and he ...
The attacks appear intended to steal the credentials of executives and officials at global organizations involved in the refrigeration process necessary to protect vaccine doses.
As the United States enters what may be the most intense stage of the pandemic yet, the Trump administration remains largely disengaged.